HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $21 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a Buy and maintains $21 price target.

byBenzinga Newsdesk

March 7, 2023

1 minute read

HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a Buy and maintains $21 price target.

Needham Initiates Coverage On Esports Technologies with Buy Rating, Announces Price Target of $18

By Benzinga Newsdesk

February 7, 8:05 AM

Needham analyst Chris Pierce initiates coverage on Esports Technologies (NASDAQ:EBET) with a Buy rating and announces Price Target of $18.

EBET

Roper Technologies Q2 EPS $3.95 Beats $3.65 Estimate, Sales $1.31B Miss $1.44B Estimate

By Bill Haddad

July 22, 6:56 AM

Roper Technologies (NYSE:ROP) reported quarterly earnings of $3.95 per share which beat the analyst consensus estimate of $3.65 by 8.22 percent. This is a 5.05 percent increase over earnings of $3.76 per share from the

ROP

Sierra Wireless Partners With Orange Wholesale France; Terms Not Disclosed

By Benzinga Newsdesk

April 19, 8:11 AM

Sierra Wireless (NASDAQ:SWIR) (TSX:SW), a world leading IoT solutions provider, today announced its new partnership with Orange Wholesale France, further bolstering its access to global networks and connectivity

ORAN